Picture of Rhythm Pharmaceuticals logo

RYTM — Rhythm Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Rhythm Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

* Rhythm Pharmaceuticals Inc  RYTM.OQ  reported a quarterly
adjusted loss of 69 cents​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of -82 cents.  The mean expectation of
nine analysts for the quarter was for a loss of 71 cents per
share. Wall Street expected results to range from -80 cents
to -60 cents per share.
    * Revenue rose 51.3% to $29.08 million from a year ago;
analysts
expected $28.79 million. 
    * Rhythm Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 55 cents​.
    * The company reported quarterly net income of $33.57
million.
    * Rhythm Pharmaceuticals Inc shares had risen by 7.2% this
quarter and lost 4.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.7%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Rhythm
Pharmaceuticals Inc is $55.00 
This summary was machine generated from LSEG data August 6 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.71          -0.69          Beat
 Mar. 31 2024      -2.16          -2.35          Missed
 Dec. 31 2023      -0.70          -0.70          Met
 Sep. 30 2023      -0.74          -0.76          Missed

Recent news on Rhythm Pharmaceuticals

See all news